America February 23, 2026
Gilead to Acquire Arcellx in $7.8B Biotech Bet on Cancer Therapy
In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…
America February 23, 2026
In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…
By Rihem Akkouche
America December 15, 2025
Swedish biopharmaceutical company Swedish Orphan Biovitrum AB said Monday it has struck a deal to buy Arthrosi Therapeutics Inc., a…
By Rihem Akkouche
America November 14, 2025
Merck said Friday it will expand its respiratory-drug arsenal through a $9.2 billion agreement to acquire Cidara Therapeutics, making one…
By Rihem Akkouche
America September 29, 2025
In a high-stakes gamble that could reshape the oncology landscape, Danish biotechnology powerhouse Genmab AS announced Monday it will acquire…
By Rihem Akkouche
America September 18, 2025
Swiss pharmaceutical titan Roche Holding AG is striking a decisive chord in the biotech arena, announcing Thursday that it will…
By Rihem Akkouche
America June 23, 2025
In a move that’s set to reshape the landscape of biotech innovation, Illumina Inc. announced Monday it will acquire proteomics…
By Rihem Akkouche
America April 11, 2025
In a dramatic maneuver that blends corporate persistence with high-stakes biotech ambition, pharmaceutical contract manufacturer Future Pak LLC has publicly…
By Rihem Akkouche
America March 17, 2025
British-Swedish pharmaceutical powerhouse AstraZeneca PLC has announced a landmark deal to acquire Belgian biotech firm EsoBiotec SA for up to…
By Rihem Akkouche
America March 17, 2025
In a high-stakes move set to reshape the biotech landscape, Taiho Pharmaceutical Co. Ltd. announced Monday that it will acquire…
By Rihem Akkouche